Ozone therapy ameliorates tubulointerstitial inflammation by regulating TLR4 in adenine-induced CKD rats

References

• Zandi-Nejad K, Brenner BM. Strategies to retard the progression of chronic kidney disease. Med Clin North Am. 2005;89:489–509.
   PubMed Web of Science ®Google Scholar
• Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2012;27:901–909.
   PubMed Web of Science ®Google Scholar
• Eardley KS, Zehnder D, Quinkler M, et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int. 2006;69:1189–1197.
   PubMed Web of Science ®Google Scholar
• Li S, Gao X, Wu X, et al. Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells. Acta Biochim Biophys Sin (Shanghai). 2015;47:368–375.
   PubMed Web of Science ®Google Scholar
• Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol. 2009;113:e1–e7.
   PubMed Web of Science ®Google Scholar
• Murad S. Toll-like receptor 4 in inflammation and angiogenesis: A double-edged sword. Front Immunol. 2014;5:313.
   PubMed Web of Science ®Google Scholar
• Kazimierczak K, Kopec W, Klinger M. Toll-like receptors (TLR) in the pathogenesis of kidney diseases. Pol Merkur Lekarski. 2007;23:382–385.
   PubMedGoogle Scholar
• Anders HJ, Banas B, Schlondorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15:854–867.
   PubMed Web of Science ®Google Scholar
• Lepenies J, Eardley KS, Kienitz T, et al. Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β1 in patients with chronic kidney disease. Nephron Clin Pract. 2011;119:c97–c104.
   PubMed Web of Science ®Google Scholar
• Bocci V, Zanardi I, Borrelli E, Travagli V. Reliable and effective oxygen-ozone therapy at a crossroads with ozonated saline infusion and ozone rectal insufflation. J Pharm Pharmacol. 2012;64:482–489.
   PubMed Web of Science ®Google Scholar
• Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Med Gas Res. 2011;1:29.
   PubMedGoogle Scholar
• Di Filippo C, Marfella R, Capodanno P, et al. Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct. Inflamm Res. 2008;57:445–449.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev. 2014;2014:273475.
   PubMedGoogle Scholar
• Paoloni M, Di Sante L, Cacchio A, et al. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: A multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976). 2009;34:1337–1344.
   PubMed Web of Science ®Google Scholar
• Alvarez RG, Zamora ZB, Borrego A, Delgado R, Schulz S, Alonso Y. Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: Induced endotoxic shock in mice. Inflamm Res. 2009;58:441–443.
   PubMed Web of Science ®Google Scholar
• Vaillant JD, Fraga A, Diaz MT, et al. Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur J Pharmacol. 2013;714:318–324.
   PubMed Web of Science ®Google Scholar
• Xing B, Chen H, Wang L, Weng X, Chen Z, Li X. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury via modulation of the TLR4-NF-κB pathway. Acta Cir Bras. 2015;30:60–66.
   PubMed Web of Science ®Google Scholar
• Chen H, Xing B, Liu X, et al. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol. 2008;581:306–314.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Oura H, Okada T. Metabolic effects of dietary purine in rats. J Nutr Sci Vitaminol (Tokyo). 1982;28:519–526.
   PubMed Web of Science ®Google Scholar
• Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant. 2013;28:2038–2045.
   PubMed Web of Science ®Google Scholar
• Leon Fernandez OS, Ajamieh HH, Berlanga J, et al. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/reperfusion. Transpl Int. 2008;21:39–48.
   PubMed Web of Science ®Google Scholar
• Shehata NI, Abd-Elgawad HM, Mawsouf MN, Shaheen AA. The potential role of ozone in ameliorating the age-related biochemical changes in male rat cerebral cortex. Biogerontology. 2012;13:565–581.
   PubMed Web of Science ®Google Scholar
• El-Sawalhi MM, Darwish HA, Mausouf MN, Shaheen AA. Modulation of age-related changes in oxidative stress markers and energy status in the rat heart and hippocampus: A significant role for ozone therapy. Cell Biochem Funct. 2013;31:518–525.
   PubMed Web of Science ®Google Scholar
• Borrego A, Zamora ZB, Gonzalez R, et al. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm. 2004;13:13–19.
   PubMed Web of Science ®Google Scholar
• Wang FM, Yang YJ, Ma LL, Tian XJ, He YQ. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. Nephrology (Carlton). 2014;19:542–551.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Feng YL, Bai X, Tan XJ, Lin RC, Mei Q. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One. 2013;8:e59617.
   PubMed Web of Science ®Google Scholar
• Kadowaki D, Sumikawa S, Arimizu K, et al. Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. Life Sci. 2012;91:1304–1308.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Doi K, Maeda-Mamiya R, et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am J Pathol. 2009;174:1203–1211.
   PubMed Web of Science ®Google Scholar
• Wang B, Ding W, Zhang M, Li H, Gu Y. Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis. Cell Physiol Biochem. 2015;35:116–125.
   PubMed Web of Science ®Google Scholar
• Panganiban RP, Vonakis BM, Ishmael FT, Stellato C. Coordinated post-transcriptional regulation of the chemokine system: Messages from CCL2. J Interferon Cytokine Res. 2014;34:255–266.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005;67:1216–1233.
   PubMed Web of Science ®Google Scholar
• Plociennikowska A, Hromada-Judycka A, Borzecka K, Kwiatkowska K. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2015;72:557–581.
   PubMed Web of Science ®Google Scholar
• Hritz I, Mandrekar P, Velayudham A, et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008;48:1224–1231.
   PubMed Web of Science ®Google Scholar
• Correa-Costa M, Braga TT, Semedo P, et al. Pivotal role of toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One. 2011;6:e29004.
   PubMed Web of Science ®Google Scholar
• Yiu WH, Lin M, Tang SC. Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int Suppl (2011). 2014;4:20–25.
   PubMed Web of Science ®Google Scholar